Effect of miR-21 on apoptosis in hepatoblastoma cell through activating ASPP2/p38 signaling pathway in vitro and in vivo

References

• von Schweinitz D. Hepatoblastoma: recent developments in research and treatment. In Seminars in pediatric surgery, vol. 21, no. 1, p. 21-30. WB Saunders, 2012.
   Google Scholar
• Birch JM. Epidemiology of pediatric liver tumors, In Pediatric Liver Tumors. Berlin, Heidelberg: Springer; 2011. p. 15-26.
   Google Scholar
• Perilongo G, Malogolowkin M, Feusner J. Hepatoblastoma clinical research: lessons learned and future challenges. Pediatr Blood Cancer. 2012;59:818–821.
   PubMed Web of Science ®Google Scholar
• Lieber J, Kirchner B, Eicher C, et al. Inhibition of Bcl‐2 and Bcl‐X enhances chemotherapy sensitivity in hepatoblastoma cells. Pediatr Blood Cancer. 2010;55:1089–1095.
   PubMed Web of Science ®Google Scholar
• Marin J, Romero M, Martinez-Becerra P, et al. Overview of the molecular bases of resistance to chemotherapy in liver and gastrointestinal tumours. CMM. 2009;9(9):1108–1129.
   PubMed Web of Science ®Google Scholar
• Engels BM, Hutvagner G. Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene. 2006;25(46):6163.
   PubMed Web of Science ®Google Scholar
• Seike M, Goto A, Okano T, et al. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc Natl Acad Sci. 2009;106(29):12085–12090.
   PubMed Web of Science ®Google Scholar
• Samuels-Lev Y, O'Connor DJ, Bergamaschi D, et al. ASPP proteins specifically stimulate the apoptotic function of p53. Mol cell. 2001;8(4):781–794.
   PubMed Web of Science ®Google Scholar
• Lossos IS, Natkunam Y, Levy R, et al. Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma: correlation with clinical outcome. Leuk lymphoma. 2002;43:2309–2317.
   PubMed Web of Science ®Google Scholar
• Papagiannakopoulos T, Shapiro A, Kosik KS. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res. 2008;68(19):8164–8172.
   PubMed Web of Science ®Google Scholar
• Roebuck DJ, Aronson D, Clapuyt P, et al. 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol. 2007;37(2):123–132.
   PubMed Web of Science ®Google Scholar
• Anaya J. OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAs. PeerJ Comput Sci. 2016;2:e67.
   Web of Science ®Google Scholar
• Cui Y, Lu P, Song G, et al. Involvement of PI3K/Akt, ERK and p38 signaling pathways in emodin-mediated extrinsic and intrinsic human hepatoblastoma cell apoptosis. Food Chem Toxicol. 2016;92:26–37.
   PubMed Web of Science ®Google Scholar
• Doberstein K, Steinmeyer N, Hartmetz A-K, et al. MicroRNA-145 targets the metalloprotease ADAM17 and is suppressed in renal cell carcinoma patients. Neoplasia. 2013;15(2):218.
   PubMed Web of Science ®Google Scholar
• Doberstein K, Bretz NP, Schirmer U, et al. miR-21-3p is a positive regulator of L1CAM in several human carcinomas. Cancer Lett. 2014;354(2):455–466.
   PubMed Web of Science ®Google Scholar
• Zhang FZ, Ho DH-H, Wong RH-F. Triptolide, a HSP90 middle domain inhibitor, induces apoptosis in triple manner. Oncotarget. 2018;9(32):22301.
   PubMedGoogle Scholar
• Pulito C, Mori F, Sacconi A, et al. Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities. Cell Discov. 2017;3(1):17022.
   PubMed Web of Science ®Google Scholar
• Liu W, Xia P, Feng J, et al. MicroRNA-132 upregulation promotes matrix degradation in intervertebral disc degeneration. Exp Cell Res. 2017;359(1):39–49.
   PubMed Web of Science ®Google Scholar
• He X, Chang Y, Meng F, et al. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene. 2012;31(28):3357.
   PubMed Web of Science ®Google Scholar
• Wang P, Zou F, Zhang X, et al. microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res. 2009;69(20):8157–8165.
   PubMed Web of Science ®Google Scholar
• Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005;65(14):6029–6033.
   PubMed Web of Science ®Google Scholar
• Liu W, Chen S, Liu B. Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study. Pediatr Surg Int. 2016;32(11):1059–1065.
   PubMed Web of Science ®Google Scholar
• Gyugos M, Lendvai G, Kenessey I, et al. MicroRNA expression might predict prognosis of epithelial hepatoblastoma. Virchows Arch. 2014;464(4):419–427.
   PubMed Web of Science ®Google Scholar
• Liu M-F, Jiang S, Lu Z, et al. Physiological and pathological functions of mammalian microRNAs; 2010; 427–446.
   Google Scholar
• Koff JL, Ramachandiran S, Bernal-Mizrachi L. A time to kill: targeting apoptosis in cancer. IJMS. 2015;16(2):2942–2955.
   Web of Science ®Google Scholar
• Yan LX, Wu QN, Zhang Y, et al. Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth. Breast cancer Res. 2011;13(1):R2.
   PubMed Web of Science ®Google Scholar
• Buscaglia LEB, Li Y. Apoptosis and the target genes of microRNA-21. Chinese J Cancer. 2011;30(6):371.
   PubMedGoogle Scholar
• Wang G, Lemos JR, Iadecola C. Herbal alkaloid tetrandrine: from an ion channel blocker to inhibitor of tumor proliferation. Trends Pharmacol Sci. 2004;25(3):120–123.
   PubMed Web of Science ®Google Scholar
• Tseng S-H, Wang C-H, Lin S-M, et al. Activation of c-Jun N-terminal kinase 1 and caspase 3 in the tamoxifen-induced apoptosis of rat glioma cells. J Cancer Res Clin Oncol. 2004;130(5):285–293.
   PubMed Web of Science ®Google Scholar
• Manke IA, Nguyen A, Lim D, et al. MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. Mol cell. 2005;17(1):37–48.
   PubMed Web of Science ®Google Scholar